Peripheral Neuropathies
Charcot-Marie-Tooth disease: CMT2, CMT4, and others
Sep. 10, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Antiphospholipid syndrome is a rare autoimmune disorder caused when antibodies—immune system cells that fight off bacteria and viruses—mistakenly attack normal proteins in the blood. Specific antibodies activate the inner lining of blood vessels, which leads to the formation of blood clots in arteries or veins in the brain, legs, kidneys, and lungs.
Antiphospholipid syndrome is sometimes called “sticky blood syndrome” because of the increased tendency for blood clots to form. A clot that forms in the brain can interrupt the flow of blood and cause a stroke. Other neurologic symptoms may include:
Antiphospholipid syndrome affects fewer than 200,000 people. Treatment is aimed at thinning the blood to prevent clots from forming and to keep existing clots from getting larger. Treatment should be lifelong. Doctors often recommend that individuals stop smoking, exercise regularly, and eat a healthy diet to prevent high blood pressure and diabetes, which are diseases that increase the risk for stroke.
How can I or my loved one help improve care for people with antiphospholipid syndrome?
Consider participating in a clinical trial so clinicians and scientists can learn more about antiphospholipid syndrome and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease.
All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.
For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with antiphospholipid syndrome at Clinicaltrials.gov.
Where can I find more information about antiphospholipid syndrome?
Information is available through the following resources:
Genetic and Rare Diseases (GARD) Information Center
National Institute of Neurological Disorders and Stroke. NINDS Antiphospholipid Syndrome Information Page. Available at: https://www.ninds.nih.gov/health-information/disorders/antiphospholipid-syndrome. Accessed July 7, 2023.
The information in this document is for general educational purposes only. It is not intended to substitute for personalized professional advice. Although the information was obtained from sources believed to be reliable, MedLink LLC, its representatives, and the providers of the information do not guarantee its accuracy and disclaim responsibility for adverse consequences resulting from its use. For further information, consult a physician and the organization referred to herein.
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125